SCHEMBL1900451

SCHEMBL1900451

CCS(=O)(=O)c1c[c]c(O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.44
PSIP1 O75475 2/20 0.43
KMT2A Q03164 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
ENPP2 Q13822 1/20 0.34
ALDH1A1 P00352 3/20 0.33
POLB P06746 2/20 0.33
CA2 P00918 1/20 0.33
ESR1 P03372 1/20 0.33
RORC P51449 2/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
MAPT P10636 1/20 0.32
ACSS2 Q9NR19 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3591711 0.79 ENPP2 (0.52) ENPP2
SCHEMBL27777602 0.78 GAA (0.45) GAAPSIP1KMT2ACYP2C9CYP2C19
SCHEMBL17290260 0.78 GAA (0.45) GAAPSIP1CYP2C9CYP2C19ALDH1A1
SCHEMBL5178148 0.77 LMNA (0.50) GAATDP1CYP2D6CYP2C9CYP2C19
SCHEMBL17748862 0.76 GAA (0.44) GAAPSIP1CYP2C9CYP2C19ALDH1A1
SCHEMBL193882 0.76 GAA (0.44) GAAPSIP1CYP2C9CYP2C19ALDH1A1
SCHEMBL10944302 0.75 CA9 (0.54) KMT2AALDH1A1CA2MEN1RAB9A
SCHEMBL6389945 0.75 CA2 (0.52) GAAKMT2ATDP1CYP2C19ALDH1A1
SCHEMBL28854341 0.73 GAA (0.41) GAAPSIP1ALDH1A1POLBRORC
SCHEMBL10455034 0.72 PSIP1 (0.74) GAAPSIP1KMT2ACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0978015-B1 LIGHT ABSORBING POLYMERS AZ ELECTRONIC MATERIALS USA (US) 2007-06-13 EP claimed
CN-1160599-C Light-absorbing polymers 克拉里安特国际有限公司 2004-08-04 CN claimed
US-5994430-A POLYMER CONTAINING A UNSATURATED PHENOL COMPOUND CLARIANT FINANCE BVI) LIMITED (VG) 1999-11-30 US claimed
US-5981145-A CONTAINING A COPOLYMER OF MODIFIED HYDROXYSTYRENE MONOMER AND AN ETHYLENICALLY UNSATURATED MONOMER FREE OF AROMATIC RING, SUITABLE FOR ANTIREFLECTIVE COATING CLARIANT FINANCE (BVI) LIMITED (VG) 1999-11-09 US claimed
US-8455477-B2 Therapeutic compounds MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-20110207711-A1 Therapeutic Compounds MSD K.K. (JP) 2011-08-25 US disclosed
EP-2320907-A1 THERAPEUTIC COMPOUNDS Merck & Co., Inc. (US) 2011-05-18 EP disclosed
WO-2010017047-A1 THERAPEUTIC COMPOUNDS MERCK & CO., INC. (US) 2010-02-11 WO disclosed
EP-0978015-B1 LIGHT ABSORBING POLYMERS AZ ELECTRONIC MATERIALS USA (US) 2007-06-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110207711-A1 Therapeutic Compounds WEE2, MARK3, WEE1 GAA 2408/4885PSIP1 2668/4885KMT2A 2181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.